¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cartilage graft"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cartilage bone
    ¿¬°ñ»À
  • cartilage lacuna
    ¿¬°ñ¼¼Æ÷¹æ
  • cartilage matrix
    ¿¬°ñ¹ÙÅÁÁú, ¿¬°ñ±âÁú
  • cartilage-hair hypoplasia
    ¿¬°ñÅÐÇü¼ºÀúÇÏÁõ
  • calcified cartilage
    ¼®È¸È­¿¬°ñ
  • elastic cartilage
    ź·Â¿¬°ñ
  • epiglottic cartilage
    Èĵε¤°³¿¬°ñ, Èĵΰ³¿¬°ñ
  • epiphyseal cartilage
    »À³¡¿¬°ñ, °ñ´Ü¿¬°ñ
  • fibrous cartilage
    ¼¶À¯¿¬°ñ
  • floating cartilage
    ¶á¿¬°ñ
  • gingival cartilage
    ÀÕ¸ö¿¬°ñ
  • greater alar cartilage
    Å«Äà¹æ¿ï¿¬°ñ, ´ëºñÀÍ¿¬°ñ
  • hyaline cartilage
    À¯¸®¿¬°ñ
  • interarticular cartilage
    °üÀý»çÀÌ¿¬°ñ, °üÀý°£¿¬°ñ
  • intervertebral cartilage
    ôÃß(»çÀÌ)¿ø¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cellular cartilage
    ¼¼Æ÷¿¬°ñ
  • connecting cartilage
    ¿¬°á¿¬°ñ, °áÇÕ¿¬°ñ
  • corniculate cartilage
    ÀܻԿ¬°ñ
  • costal cartilage
    °¥ºñ¿¬°ñ
  • cricoid cartilage
    ¹ÝÁö¿¬°ñ
  • cuneiform cartilage
    ½û±â¿¬°ñ
  • elastic cartilage
    ź·Â¿¬°ñ
  • epiglottic cartilage
    Èĵε¤°³¿¬°ñ
  • epiphyseal cartilage
    »À³¡¿¬°ñ
  • fibrous cartilage
    ¼¶À¯¿¬°ñ
  • floating cartilage
    ¶á¿¬°ñ
  • gingival cartilage
    ÀÕ¸ö¿¬°ñ
  • greater alar cartilage
    Å«Äà¹æ¿ï¿¬°ñ
  • hyaline cartilage
    À¯¸®¿¬°ñ
  • interarticular cartilage
    °üÀý»çÀÌ¿¬°ñ, °üÀý°£¿¬°ñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • greater alar cartilage
    Å«Äà¹æ¿ï¿¬°ñ
  • growing cartilage
    ¼ºÀ忬°ñ
  • heteroplasia (renal cartilage)
    ´Ù¸¥Á¶Á÷Çü¼º (ÄáÆÏ¿¬°ñ)
  • petrosal cartilage of temporal bone
    °üÀÚ»À¹ÙÀ§¿¬°ñ
  • posterior process of septal nasal cartilage
    µÚµ¹±â
  • quadrate cartilage
    ³×¸ð¿¬°ñ
  • Graft
    Á¶Á÷À̽Ä(ðÚòÄì¹ãÕ), ÀÌ½ÄÆí(ì¹ãÕø¸)
  • alloplastic graft
    ¹«»ý¹°Àç·áÀÌ½ÄÆí(ÙíßæÚªî§è÷ì¹ãÕø¸).
  • animal graft
    µ¿¹°½ÄÇÇ(¡­½ÄÇÇ).
  • artificial skin graft
    Àΰø ÇǺÎÀ̽Ä
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free jejunal graft
    À¯¸®°øÀå À̽ļú
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ÇǺÎÀÌ½ÄÆí), ÀüÃþ½ÄÇÇ(¡­½ÄÇÇ).
  • full thickness graft
    ÀüÃþÇǺÎÀÌ½ÄÆí(¡­ù«Ý±ì¹ãÕø¸), ÀüÃþ½ÄÇÇ(¡­ãÕù«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • coronary artery bypass graft
    °ü»óµ¿¸Æ¿ìȸ·Î¼úÀ̽Ä(¼ú).
  • cultured keratinocyte graft
    ¹è¾ç°¢Áú¼¼Æ÷ À̽Ä
  • dermic graft
    ½ÄÇÇ(½ÄÇÇ).
  • dermis graft
    ÁøÇÇÀ̽Ä
  • double-end graft
    ½Ö´ÜÀ̽Ä.
  • dural graft
    °æ¸·À̽Ä(°æ¸·À̽Ä).
  • epidermic graft
    Ç¥ÇÇÀ̽Ä(¡­ì¹ãÕ).
  • fascia graft
    ±Ù¸· À̽Ä(ÐÉØ¯ì¹ãÕ).
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ÀÌ½ÄÆí).
  • fat graft
    Áö¹æÀ̽Ä
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ì¹ãÕø¸).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free jejunal graft
    À¯¸®°øÀå À̽ļú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Accessory nasal cartilage
    µ¡ÄÚ¿¬°ñ
    [¿¾ ¿ë¾î] ºÎºñ¿¬°ñ
  • Posterior process of septal nasal cartilage
    µÚµ¹±â
    [¿¾ ¿ë¾î] Èĵ¹±â
  • Occipital cartilage
    µÚÅë¼ö»À¿¬°ñ
    [¿¾ ¿ë¾î] Èĵο¬°ñ
  • Dorsal cartilage
    µîÂÊ¿¬°ñ
    [¿¾ ¿ë¾î] ¹èÃø¿¬°ñ
  • Arytenoid cartilage
    ¸ð»Ô¿¬°ñ
    [¿¾ ¿ë¾î] ÇÇ¿­¿¬°ñ
  • Basihyoid cartilage
    ¸ñ»Ô»À¹Ù´Ú¿¬°ñ
    [¿¾ ¿ë¾î] ¼³°ñÀú¿¬°ñ
  • Ceratohyoid cartilage
    ¸ñ»Ô»ÀÀÛÀº»Ô¿¬°ñ
    [¿¾ ¿ë¾î] ¼³°ñ¼Ò°¢¿¬°ñ
  • Epihyoid cartilage
    ¸ñ»ÔÀ§¿¬°ñ
    [¿¾ ¿ë¾î] ¼³»ó¿¬°ñ
  • Triticeal cartilage
    ¹Ð¾Ë¿¬°ñ
    [¿¾ ¿ë¾î] ¸Æ¸³¿¬°ñ
  • Cartilage of acoustic meatus
    ¹Ù±ù±Í±æ¿¬°ñ
    [¿¾ ¿ë¾î] ¿ÜÀ̵µ¿¬°ñ
  • Cricoid cartilage
    ¹ÝÁö¿¬°ñ
    [¿¾ ¿ë¾î] À±»ó¿¬°ñ
  • THYROID CARTILAGE
    ¹æÆÐ¿¬°ñ [°©»ó¿¬°ñ]
    [¿¾ ¿ë¾î] °©»ó¿¬°ñ
  • Embryonic cartilage
    ¹èÀÚ¿¬°ñ
    [¿¾ ¿ë¾î] ¹èÀÚ¿¬°ñ
  • Ventral cartilage
    ¹èÂÊ¿¬°ñ
    [¿¾ ¿ë¾î] º¹Ãø¿¬°ñ
  • Ethmoidal cartilage
    ¹úÁý»À¿¬°ñ
    [¿¾ ¿ë¾î] »ç°ñ¿¬°ñ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • septal cartilage
    ÄÚÁß°Ý¿¬°ñ, ºñÁß°Ý¿¬°ñ
  • thyroid cartilage
    °©»ó¿¬°ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMP cardiomyopathy; cartilage matrix protein; chondromalacia patellae; collagen binding protein; competi...
COMP cartilage oligomeric matrix protein; complication; cyclophosphamide, vincristine, methotrexate, pred...
CRTM cartilage matrix protein
MAGIC microprobe analysis generalized intensity correction; mouth (or mucosal) and genital ulceration with...
CABG Coronary Artery Bypass Graft
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AGVHD Acute graft-versus-host disease
aGVHD Acute graft-vs.-host disease
CABG CORONARY ARTERY BYPASS GRAFT
cGVHD Chronic graft versus host disease
cGVHD Chronic graft-vs.-host disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ceratohyoid cartilage
    ¸ñ»Ô»À ÀÛÀº »Ô ¿¬°ñ
  • columns of cartilage cell
    ¿¬°ñ ¼¼Æ÷ ±âµÕ, ¿¬°ñ ¼¼Æ÷ÁÖ
  • costi-cartilage
    ´Á ¿¬°ñ
  • cricoid cartilage
    À±»ó ¿¬°ñ
    ÈĵÎÀÇ ÃÖÇÏ¹æ ¿¬°ñ. ¹æÆÐ ¿¬°ñ ¹Ø¿¡ À§Ä¡ÇÏ´Â °¡¶ôÁö ¸ð¾çÀÇ ¿¬°ñ·Î¼­ ¾ÕÂÊÀº °¡´À´Ù¶õ ȰÀ» ÀÌ·ç°í ÀÖ°í, µÚÂÊÀº ³ÐÁ÷ÇÑ ÆÇÀ» ÀÌ·ç°í ÀÖ´Ù.
  • cuneiform cartilage
    ½û±â ¿¬°ñ, ¼³»ó ¿¬°ñ
  • ear canal cartilage
    À̵µ ¿¬°ñ
  • epiphyseal cartilage
    °ñ³¡ ¿¬°ñ, °ñ´Ü ¿¬°ñ
  • fetal cartilage
    ų» ¿¬°ñ
  • interarticular cartilage
    °üÀý°£ ¿¬°ñ
  • laryngeal cartilage
    Èĵο¬°ñ
    Èĵΰ³ÀÇ ³»ºÎ¿¡ Àִ ź·Â¼ºÀÌ Ç³ºÎÇÑ ÇϳªÀÇ ¿¬°ñ.
  • nasal cartilage
    ÄÚ ¿¬°ñ, ºñ ¿¬°ñ
  • paranasal cartilage
    ºÎºñ ¿¬°ñ
  • accordion graft
    ¾ÆÄÚµð¿Â ½ÄÇÇ
    ÀÛ°í ¸¹Àº Àý°³¸¦ °¡ÇÑ ÀüÃþ ÇǺΠÀÌ½ÄÆíÀ¸·Î ³ÐÀº ºÎÀ§¸¦ µ¤±â À§ÇØ Æì¼­ »ç¿ëÇÑ´Ù.
  • alloplastic graft
    ¹«»ý¹° Àç·á ÀÌ½ÄÆí, À̹°¼ºÇü¼ú
    ºñȰ¼º ¹°ÁúÀ» ÀÌ¿ëÇÏ´Â À̽ļú.
  • alveolar bone graft
    Ä¡Á¶°ñ À̽Ä, Ä¡Á¶°ñ À̽ļú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vascularised graft The state of a graft after the recipient vasculature has been connected with the vessels in the graft.
(05 Mar 2000)
partial-thickness graft A graft of portions of the skin, i.e., the epidermis and part of the dermis, or of part of the mucosa and submucosa, but not including the periosteum.
Synonym: partial-thickness graft, split-skin graft.
(05 Mar 2000)
pedicle graft A skin flap sustained by a blood-carrying stem from the donor site during transfer, in periodontal surgery, a flap used to increase the width of attached gingiva, or to cover a root surface, by moving the attached gingiva, which remains joined at one side, to an adjacent position and suturing the free end.
(05 Mar 2000)
Reverdin graft Small bits of skin, of partial or full thickness, removed from a healthy area and seeded in a site to be covered.
Synonym: Reverdin graft.
(05 Mar 2000)
graft To insert scions from one tree, or kind of tree, etc, into another; to practice grafting.
A small shoot or scion of a tree inserted in another tree, the stock of which is to support and nourish it. The two unite and become one tree, but the graft determines the kind of fruit.
A branch or portion of a tree growing from such a shoot.
<surgery> A portion of living tissue used in the operation of autoplasty.
Origin: OE. Graff, F. Greffe, originally the same word as OF. Grafe pencil, L. Graphium, Gr, fr. To write; prob. Akin to E. Carve. So named from the resemblance of a scion or shoot to a pointed pencil. Cf. Graphic, Grammar.
1. To insert (a graft) in a branch or stem of another tree; to propagate by insertion in another stock; also, to insert a graft upon. [Formerly written graff.
2.
<surgery> To implant a portion of (living flesh or akin) in a lesion so as to form an organic union.
3.
To join (one thing) to another as if by grafting, so as to bring about a close union. "And graft my love immortal on thy fame !" (Pope)
4.
To cover, as a ring bolt, block strap, splicing, etc, with a weaving of small cord or rope-yarns.
Origin: F. Greffer. See Graft.
Source: Websters Dictionary
(01 Mar 1998)
graft enhancement, immunologic The induction of prolonged survival and growth of allografts of either tumours or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunised donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity.
(12 Dec 1998)
graft occlusion <physiology> Obstruction of flow in biological or prosthetic vascular grafts.
(12 Dec 1998)
graft rejection <haematology, immunology> When donated bone marrow infused during a bone marrow transplant is rejected by the patients body or does not take.
(16 Dec 1997)
graft survival <haematology> The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.
(12 Dec 1998)
graft-versus-host disease <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host reaction <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
graft-versus-host response <haematology> A common and serious, complication of bone marrow transplantation where there is a reaction of donated bone marrow against a patient's own tissue.
When donor lymphocytes or a graft containing lymphocytes that are immunologically competent are given to a patient that has low immunological competence, an incompatibility reaction can result. This is due to antibodies from the donor against antigens in the host. This is due to mismatch of MHC Class I antigens and can produce lymphocyte clones that will react by a variety of processes against the host and cause damage.
The clinical condition can be fatal and is due to the donor's immune cells recognising the host cells as foreign.
The clinical entity characterised by anorexia, diarrhoea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the graft-versus-host reaction. It can occur in either chronic or acute forms and is treatable by immunosuppressive drugs.
Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.
Radiological appearances of the gastrointestinal tract include; thickened wall, mucosal folds thickened or effaced, increased secretions most likely to be rapid transit of GI tract, mass most likely to be focal oedema, fibrosis, hallmark: diffuse, uniform thickening of small bowel.
Synonym: GVH disease.
Acronym: GVHD
(20 Sep 2002)
mesh graft A skin graft in which multiple slits have been made, so it can be stretched to cover a large area.
Synonym: mesh graft.
(05 Mar 2000)
periosteal graft A graft of periosteum, usually placed on bare bone.
(05 Mar 2000)
chip graft A graft utilizing small pieces of cartilage or bone which is packed into a bone defect.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á